Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Choosing between small-cap index funds and total market exposure affects risk and return in retirement. This comparison highlights key differences and decisions.
28,577 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
NVIDIA continues to outpace AMD in data-center AI hardware even as a Kyber rack delay looms, reinforcing Nvidia’s moa...
ServiceNow could deliver durable growth as organizations automate more workflows. This article lays out the bull case...
Tom Lee has sparked headlines with bold targets for Bitcoin and Ethereum. This deep dive breaks down the realism, the...
Big Tech is hiring high-salary communications leaders who don’t code, aiming to reduce risk and boost clarity amid ra...
MBA Chief Bob Broeksmit calls for relief from cost-adding rules as mortgage rates remain elevated, urging targeted re...
Sabre, a travel-technology stalwart, is navigating a recovering travel market and shifting tech spend. This article b...
The AI wave doesn’t have to ride on flashy tech stocks. This article shows how certain energy stocks can capture AI-d...
Dallas-Fort Worth is seeing a growth shift to the south, as new toll corridors and job centers spur homebuilding and ...
As AI workloads surge, power reliability becomes a strategic bottleneck for data centers. This utility stock could of...
Small modular reactor stocks trading under $10 can look tempting, but prices don’t always reflect real value. This gu...
Investors are watching RFK Jr.’s carnivore diet stance as a health trend with potential implications for meat, dairy,...